Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ovensa Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11092
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ovensa Inc (Ovensa) is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan Nanomedicine delivery platform that has mucosal and brain-barrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in the delivery of various drugs across multiple barriers such as blood-brain barrier, buccal, bronchial, cornea and conjunctiva, dermal, female reproductive tract, gastrointestinal tract, nasal, and others. Ovensa’s platform find applications in the mucosal delivery of peptides, vaccines, DNA and RNA, gene-based therapies, and other biologics and conventional small molecules. The company also conducts programs for the treatment of metastatic breast cancer, glioblastoma, autism, Alzheimer’s disease, and other diseases. It partners with pharmaceutical and biotech companies. Ovensa is headquartered in Aurora, Ontario, Canada.

Ovensa Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ovensa Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ovensa Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ovensa Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Ovensa Enters into Licensing Agreement with Aligo Innovation 10
Ovensa Enters into Licensing Agreement with SOCPRA 11
Gestion Socpra Enters into Licensing Agreement with Ovensa 12
Ovensa Inc – Key Competitors 13
Ovensa Inc – Key Employees 14
Ovensa Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Ovensa Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ovensa Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ovensa Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ovensa Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ovensa Enters into Licensing Agreement with Aligo Innovation 10
Ovensa Enters into Licensing Agreement with SOCPRA 11
Gestion Socpra Enters into Licensing Agreement with Ovensa 12
Ovensa Inc, Key Competitors 13
Ovensa Inc, Key Employees 14

List of Figures
Ovensa Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ovensa Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fresenius Medical Care AG & Co KGaA (FMS):医療機器:M&Aディール及び事業提携情報
    Summary Fresenius Medical Care AG & Co KGaA (Fresenius Medical), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It is one of the largest kidney dialysis companies in the world. It provides dialysis care services and products to individuals with chronic kidney failure. It …
  • Itochu Chemical Frontier Corp-製薬・医療分野:企業M&A・提携分析
    Summary Itochu Chemical Frontier Corp (ICF), formerly Ando Kaseihin KK, a subsidiary of Itochu Corporation, is a chemical company that manufactures and markets chemical products. The company operates in intermediate chemical division, silicone and adhesive division, osaka and nagoya division, perfor …
  • West Cornwall Pasty Co. Ltd:企業の戦略・SWOT・財務分析
    West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sonoma Pharmaceuticals Inc (SNOA):医療機器:M&Aディール及び事業提携情報
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Veracyte Inc (VCYT):企業の製品パイプライン分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products comprise Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It als …
  • Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatmen …
  • Jiuzhitang Co Ltd (000989):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiuzhitang Co Ltd (Jiuzhitang), formerly Labor Jiuzhitang Pharmacy, is a Chinese medicine manufacturing company. The company offers products such as shuxuetong injection, lujiao granule, liuwei dihuang wan pills, zuguang power, siqikang injection, luo hua zi zhu tablets, compound jiangzhi ta …
  • Integer Holdings Corp (GB):企業の財務・戦略的SWOT分析
    Summary Integer Holdings Corp (Integrated Holdings), formerly Greatbatch Inc is a medical device outsource manufacturer that designs and develops medical devices and power solutions for the medical and non-medical markets. The company offers products such as arthroscopic devices and components, lapa …
  • MISC Berhad:企業の戦略・SWOT・財務分析
    MISC Berhad - Strategy, SWOT and Corporate Finance Report Summary MISC Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Motor Oil (Hellas) Corinth Refineries SA (MOH):企業の財務・戦略的SWOT分析
    Motor Oil (Hellas) Corinth Refineries SA (MOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Discovery Holdings Limited (DSY):企業の財務・戦略的SWOT分析
    Discovery Holdings Limited (DSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Toyo Tanso Co Ltd (5310):企業の財務・戦略的SWOT分析
    Toyo Tanso Co Ltd (5310) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bharat Petroleum Corp Ltd (BPCL):石油・ガス:M&Aディール及び事業提携情報
    Summary Bharat Petroleum Corp Ltd (BPCL) is an integrated oil and gas company. It carries out production of oil and natural gas; refining of crude oil; and marketing and distribution of petroleum products. The company also focuses on renewable energy. It produces oil products including light distill …
  • Industrias Penoles SAB de CV:企業の戦略・SWOT・財務情報
    Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Daiwa Securities Group Inc:企業のM&A・事業提携・投資動向
    Daiwa Securities Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daiwa Securities Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Cabela’S Inc:企業の戦略・SWOT・財務分析
    Cabela'S Inc - Strategy, SWOT and Corporate Finance Report Summary Cabela'S Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Oil India Limited:企業の戦略・SWOT・財務分析
    Oil India Limited - Strategy, SWOT and Corporate Finance Report Summary Oil India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Endeavour Mining Corporation:企業の戦略・SWOT・財務情報
    Endeavour Mining Corporation - Strategy, SWOT and Corporate Finance Report Summary Endeavour Mining Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • AveXis Inc (AVXS):製薬・医療:M&Aディール及び事業提携情報
    Summary AveXis Inc (AveXis), formerly BioLife Cell Bank Inc, is a biotechnology company that develops innovative treatments for rare and potentially fatal neurological genetic diseases. The company offers AVXS-101, a proprietary gene therapy candidate in phase 1 targeted at the treatment of spinal m …
  • Titan Pharmaceuticals Inc (TTNP):企業の財務・戦略的SWOT分析
    Summary Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆